Regístrese
metricas
covid
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-p...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Original article
Comparison of performance of MALDI-TOF MS and MLST for biotyping carbapenemase-producing Klebsiella pneumoniae sequence types ST11 and ST101 isolates
Estudio comparativo de la utilidad de MALDI-TOF MS y MLST para el biotipado de Klebsiella pneumoniae ST11 y ST101 productoras de carbapenemasas
Irene Penaa, Eduardo Pena-Vinab, Iciar Rodriguez-Avialc, Juan J. Picazod, Álvaro Gómez-Gonzáleze, Esther Culebrasc,d,
Corresponding author
esther.culebras@salud.madrid.org

Corresponding author.
a Servicio de Microbiología, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain
b Alisio Computing GmbH, Kaiserslautern, Germany
c Servicio de Microbiología Clínica, Hospital Clínico San Carlos, IdISCC and IML Institutes, Germany
d Departamento de Medicina, Facultad de Medicina, Universidad Complutense, Madrid, Spain
e BD Integrated Diagnostic Solutions, San Agustín de Guadalix, Madrid, Spain
Read
2051
Times
was read the article
795
Total PDF
1256
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2020.10.018
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 25 16 41
2024 October 30 13 43
2024 September 43 25 68
2024 August 39 17 56
2024 July 31 22 53
2024 June 32 25 57
2024 May 33 24 57
2024 April 23 26 49
2024 March 58 18 76
2024 February 54 24 78
2024 January 42 36 78
2023 December 58 36 94
2023 November 56 32 88
2023 October 47 38 85
2023 September 63 11 74
2023 August 52 10 62
2023 July 48 67 115
2023 June 42 28 70
2023 May 71 29 100
2023 April 88 44 132
2023 March 42 18 60
2023 February 36 29 65
2023 January 54 18 72
2022 December 49 16 65
2022 November 53 25 78
2022 October 21 15 36
2022 September 5 48 53
2022 August 0 31 31
2022 July 0 2 2
2022 June 8 6 14
2022 May 5 7 12
2022 April 48 33 81
2021 September 0 2 2
2021 July 0 2 2
2020 December 0 2 2
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Free access articles
Outpatient parenteral antibiotic therapy (OPAT)...
10.1016/j.eimc.2024.04.001
Corrigendum a: Ecografía clínica:...
Enferm Infecc Microbiol Clin. 2024;42:281
The current status of arboviruses with major...
Enferm Infecc Microbiol Clin. 2024;42:516-26


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos